tiprankstipranks
Trending News
More News >
InnoCan Pharma (INNPF)
OTHER OTC:INNPF
US Market

InnoCan Pharma (INNPF) Technical Analysis

Compare
13 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
5Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
InnoCan Pharma’s (INNPF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting InnoCan Pharma is a Sell.
InnoCan Pharma’s (INNPF) 20-Day exponential moving average is 0.12, while InnoCan Pharma’s (INNPF) share price is $0.12, making it a Sell.
InnoCan Pharma’s (INNPF) 50-Day exponential moving average is 0.12, while InnoCan Pharma’s (INNPF) share price is $0.12, making it a Sell.

InnoCan Pharma (INNPF) Pivot Points

May 11, 2025, 03:33 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.09
0.10
0.11
0.12
0.13
0.14
0.15
Fibonacci
0.10
0.11
0.11
0.12
0.13
0.13
0.14
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

InnoCan Pharma (INNPF) Moving Averages

May 11, 2025, 03:33 PM
Period
Simple
Exponential
MA5
0.12Buy
0.12Buy
MA10
0.12Buy
0.12Buy
MA20
0.12Sell
0.12Sell
MA50
0.13Sell
0.12Sell
MA100
0.13Sell
0.13Sell
MA200
0.14Sell
0.14Sell
InnoCan Pharma’s (INNPF) 10-Day exponential moving average is 0.12, while InnoCan Pharma’s (INNPF) share price is $0.12, making it a Buy.
InnoCan Pharma’s (INNPF) 100-Day exponential moving average is 0.13, while InnoCan Pharma’s (INNPF) share price is $0.12, making it a Sell.
InnoCan Pharma’s (INNPF) stock price is $0.12 and InnoCan Pharma’s (INNPF) 50-day simple moving average is 0.13, creating a Sell signal.
InnoCan Pharma’s (INNPF) stock price is $0.12 and InnoCan Pharma’s (INNPF) 100-day simple moving average is 0.13, creating a Sell signal.
InnoCan Pharma’s (INNPF) stock price is $0.12 and InnoCan Pharma’s (INNPF) 200-day simple moving average is 0.14, creating a Sell signal.

InnoCan Pharma (INNPF) Technical Indicators

May 11, 2025, 03:33 PM
Name
Value
Implied Action
RSI (14)
45.68
Neutral
STOCH (9,6)
67.08
Neutral
STOCHRSI (14)
58.33
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
51.17
Sell
Williams %R
-41.67
Buy
CCI (14)
-40.59
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
53.95
Neutral
ROC
0.00
Sell
InnoCan Pharma’s (INNPF) Relative Strength Index (RSI) is 45.68, creating a Neutral signal.
InnoCan Pharma’s (INNPF) Trend Strength Indicator (ADX) is 51.17, creating a Sell signal.
InnoCan Pharma’s (INNPF) Commodity Channel Index (CCI) is -40.59, creating a Neutral signal.

FAQ

Is INNPF a Buy, Hold, or Sell?
Based on INNPF’s technical indicators, INNPF is a Sell.
    What is INNPF’s RSI (14)?
    INNPF’s RSI (14) is 45.68, which suggests INNPF is a Neutral.
      What is INNPF’s MACD?
      INNPF’s MACD is >-0.01, which suggests INNPF is a Sell.
        What is INNPF’s 5-day moving average?
        INNPF’s 5-day moving average is 0.12, which suggests INNPF is a Buy.
          What is INNPF’s 20-day moving average?
          INNPF 20-day moving average is 0.12, which suggests INNPF is a Sell.
            What is INNPF’s 50-day moving average?
            INNPF’s 50-day moving average is 0.13, which suggests INNPF is a Sell.
              What is INNPF’s 200-day moving average?
              INNPF’s 200-day moving average is 0.14, which suggests INNPF is a Sell.
                What is INNPF’s Williams % R (14)?
                INNPF’s Williams % R (14) is -41.67, which suggests INNPF is a Buy.
                  What is INNPF’s CCI (14)?
                  INNPF’s CCI (14) is -40.59, which suggests INNPF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis